BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26337623)

  • 1. IDH1 mutation-associated long non-coding RNA expression profile changes in glioma.
    Zhang XQ; Kiang KM; Wang YC; Pu JK; Ho A; Cheng SY; Lee D; Zhang PD; Chen JJ; Lui WM; Fung CF; Leung GK
    J Neurooncol; 2015 Nov; 125(2):253-63. PubMed ID: 26337623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses.
    Cheng W; Ren X; Zhang C; Cai J; Han S; Wu A
    Mol Neurobiol; 2017 Oct; 54(8):5996-6005. PubMed ID: 27696222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling.
    Cui D; Ren J; Shi J; Feng L; Wang K; Zeng T; Jin Y; Gao L
    Int J Biochem Cell Biol; 2016 Apr; 73():72-81. PubMed ID: 26860959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-cancer analysis of non-coding transcripts reveals the prognostic onco-lncRNA HOXA10-AS in gliomas.
    Isaev K; Jiang L; Wu S; Lee CA; Watters V; Fort V; Tsai R; Coutinho FJ; Hussein SMI; Zhang J; Wu J; Dirks PB; Schramek D; Reimand J
    Cell Rep; 2021 Oct; 37(3):109873. PubMed ID: 34686327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular signatures classify astrocytic gliomas by IDH1 mutation status.
    Toedt G; Barbus S; Wolter M; Felsberg J; Tews B; Blond F; Sabel MC; Hofmann S; Becker N; Hartmann C; Ohgaki H; von Deimling A; Wiestler OD; Hahn M; Lichter P; Reifenberger G; Radlwimmer B
    Int J Cancer; 2011 Mar; 128(5):1095-103. PubMed ID: 20473936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZEB1 expression is increased in IDH1-mutant lower-grade gliomas.
    Nesvick CL; Zhang C; Edwards NA; Montgomery BK; Lee M; Yang C; Wang H; Zhu D; Heiss JD; Merrill MJ; Ray-Chaudhury A; Zhuang Z
    J Neurooncol; 2016 Oct; 130(1):111-122. PubMed ID: 27568035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of Long Noncoding RNA Small Nucleolar RNA Host Gene 18 Promotes Radioresistance of Glioma by Repressing Semaphorin 5A.
    Zheng R; Yao Q; Ren C; Liu Y; Yang H; Xie G; Du S; Yang K; Yuan Y
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):877-887. PubMed ID: 27788958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNAs in glioma: functional roles and clinical perspectives.
    Zhang XQ; Leung GK
    Neurochem Int; 2014 Nov; 77():78-85. PubMed ID: 24887176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma.
    Raghunathan A; Olar A; Vogel H; Parker JR; Coventry SC; Debski R; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Fuller GN
    Ann Diagn Pathol; 2012 Aug; 16(4):255-9. PubMed ID: 22445362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and prognostic value of microRNAs in lower-grade glioma depends on IDH1/2 status.
    Cheng W; Ren X; Zhang C; Han S; Wu A
    J Neurooncol; 2017 Apr; 132(2):207-218. PubMed ID: 28091987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma.
    Gravendeel LA; Kloosterhof NK; Bralten LB; van Marion R; Dubbink HJ; Dinjens W; Bleeker FE; Hoogenraad CC; Michiels E; Kros JM; van den Bent M; Smitt PA; French PJ
    Hum Mutat; 2010 Mar; 31(3):E1186-99. PubMed ID: 20077503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microfluidics for rapid detection of isocitrate dehydrogenase 1 mutation for intraoperative application.
    Aibaidula A; Zhao W; Wu JS; Chen H; Shi ZF; Zheng LL; Mao Y; Zhou LF; Sui GD
    J Neurosurg; 2016 Jun; 124(6):1611-8. PubMed ID: 26544771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IDH1 R132H mutation generates a distinct phospholipid metabolite profile in glioma.
    Esmaeili M; Hamans BC; Navis AC; van Horssen R; Bathen TF; Gribbestad IS; Leenders WP; Heerschap A
    Cancer Res; 2014 Sep; 74(17):4898-907. PubMed ID: 25005896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNAs in glioma progression.
    Xi J; Sun Q; Ma L; Kang J
    Cancer Lett; 2018 Apr; 419():203-209. PubMed ID: 29355660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA-TP53TG1 Participated in the Stress Response Under Glucose Deprivation in Glioma.
    Chen X; Gao Y; Li D; Cao Y; Hao B
    J Cell Biochem; 2017 Dec; 118(12):4897-4904. PubMed ID: 28569381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between IDH1 gene mutation status and survival of patients treated for recurrent glioma.
    Lv S; Teugels E; Sadones J; Quartier E; Huylebrouck M; DU Four S; LE Mercier M; DE Witte O; Salmon I; Michotte A; DE Grève J; Neyns B
    Anticancer Res; 2011 Dec; 31(12):4457-63. PubMed ID: 22199315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
    Hartmann C; Meyer J; Balss J; Capper D; Mueller W; Christians A; Felsberg J; Wolter M; Mawrin C; Wick W; Weller M; Herold-Mende C; Unterberg A; Jeuken JW; Wesseling P; Reifenberger G; von Deimling A
    Acta Neuropathol; 2009 Oct; 118(4):469-74. PubMed ID: 19554337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.